Results 201 to 210 of about 76,320 (330)

Healthcare Practitioner and Other Professionals' Perspectives on Gabapentinoid Misuse and Dependence: A Systematic Review of Qualitative Studies

open access: yesEuropean Journal of Pain, Volume 29, Issue 9, October 2025.
ABSTRACT Background and Objective The global rise in gabapentinoid prescriptions for chronic pain has been striking. However, this trend has been accompanied by growing concerns about misuse and dependence. This qualitative systematic review aimed to synthesise the perspectives of healthcare practitioners and other professionals on these emerging ...
Amy G. McNeilage   +4 more
wiley   +1 more source

Hexahydrocannabinol and Hexahydrocannabiphorol Poisonings: Data From the Czech Toxicology Information Centre and Effects of Legislative Changes

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 5, October 2025.
Development in the number of HHC and HHC‐P intoxications before and after the government ban on sales. ABSTRACT Hexahydrocannabinol, a hydrogenated derivative of cannabinol, first came to the Czech Toxicological Information Centre (TIC) following reports of poisonings in May 2022. We conducted a retrospective observational study examining self‐reported
Michal Čečrle   +3 more
wiley   +1 more source

Implementation of harm reduction strategies in criminal-legal systems: a scoping review of the literature. [PDF]

open access: yesHealth Justice
Johnson KL   +9 more
europepmc   +1 more source

Naloxone and Its Analeptic Effect [PDF]

open access: bronze, 1983
Mark A. Gillman, F J Lichtigfeld
openalex   +1 more source

Cardiopulmonary resuscitation in anaesthetised foals

open access: yes
Equine Veterinary Education, Volume 37, Issue 11, Page 563-567, November 2025.
K. Varner, H. Roessner
wiley   +1 more source

Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival Forest

open access: yesClinical and Translational Science, Volume 18, Issue 10, October 2025.
ABSTRACT Rare diseases affect a small population of patients, resulting in low incentives for developing orphan drug products (ODPs). The United States Congress passed the Orphan Drug Act of 1983 to incentivize pharmaceutical manufacturers to develop drugs to treat rare diseases.
Robert Hopefl   +6 more
wiley   +1 more source

Allocative efficiency analysis of strategies to reduce overdose deaths among people with opioid use disorder and history of incarceration in Connecticut. [PDF]

open access: yesBMC Public Health
Scheidell JD   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy